Message, June 11, 2012
Enzymatica conducting study with New Hair Clinic in Lund for granted international study grants.
Enzymatica is a biotechnology company focused on research, development and registration of medical devices based on a patented enzyme technology. The company is currently carrying out a joint study with the Plastic Surgery Clinic New Hair Clinic who works with hair transplants. The study aims to identify and document how a hudgel containing Enzymaticas enzyme acts at healing and convalescence in patients undergoing hair transplantation.
2010 Enzymatica began a collaboration with New Hair Clinic, the market leader in hair transplantation in Scandinavia. The aim is to offer patients and the public an alternative to the treatment of skin disorders and wound healing in general, and in patients in connection with transplants in particular.Enzymatica has developed a cosmetic hudgel, “Scar Repair Creme” of wound healing, adapted to cosmetic surgery clinic’s needs. The collaboration has developed well and are now implementing Enzymatica and New Hair Clinic, a joint study, with study grants from the International Society for Hair Restoration Surgery, ISHRS. The purpose of this study, a small proof-of-conpcept study is to investigate if we can document the effects of the enzyme-based hudgelen in the wound healing process in patients who have undergone plastic surgery:”Cod Trypsin Gel Application on implanted Scalp to ENHANCE healing and Shorten cosmetic convalescence.” The study included 20 patients and the results will be presented within approximately 1 year.
“The study is in full swing and we are proud that we have received funding for the study of the ISHRS, as there is a prominent international organization in plastic surgery. It is an exploratory study that aims to optimize the dosage and application schedule for the future. It’s also an interesting medical issue to investigate cold-adapted trypsiners effect on wound healing after surgery, “says physician and the Medical Director at New Hair Clinic, Mats Ingers.
Enzymaticas strategy is to develop and register medical products based on enzyme technology and then to market and launch the products in priority markets and channels. The company received in May its product PeriZyme ® chewing gum on plaque and bad breath registered as a medical device by the MPA. Enzymatica have also submitted applications for registration for ColdZyme ® oral spray for colds. The company plans a broader market launch in 2013 of their registered products. Enzymaticas products are already on sale in health food stores. In addition, “Scar Repair Creme” for sale at New Hair Clinic in Stockholm and Lund.
For further questions please feel free to contact;If the study: Marcus Fornbacke, Head of Research, Enzymatica, Telephone: +46 (0) 70-33 999 55 email@example.com
Mats Ingers Doctor & Medical Director, New Hair Clinic, Telephone: +46 (0) 46 14 32 80 firstname.lastname@example.org Enzymatica: Michael Edelborg Christensen, CEO Telephone: 0768-144 166 email@example.com
Enzymatica AB (publ)Enzymatica AB (publ) is a publicly traded biotechnology company focused on research, development and registration of medical devices based on a patented enzyme technology. Enzymatica uses the patented enzyme Penzyme ®, a cold adapted trypsin from deep-sea cod. The enzyme has a unique feature that allows the super-active at about 37 ° C, making it superior to break down the disease-related proteins, counter infections by viruses and bacteria and promote healing processes. ColdZyme portfolio, which today is represented in health food stores, contain precursors of the products are under registration as medical devices for colds, and dental and munhålesjukdomar.
About New Hair Clinic in Sweden AB, Scandinavia’s leading and most comprehensive clinic for hair transplant patients with 20 years in the industry. The main clinic is located in Lund, and a branch at Nybrogatan 75 in Stockholm.